Rubicon Organics, Inc.

As of June 30, 2026, Rubicon Organics, Inc. carries a market capitalization of 31.09M, placing it among publicly traded companies globally. Its enterprise value stands at 43.70M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Rubicon Organics, Inc.'s next confirmed earnings release is scheduled for November 18, 2026.

As of June 30, 2026, Rubicon Organics, Inc. has 67.58M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.50, and the price-to-book ratio stands at 0.73.

As of June 30, 2026, Rubicon Organics, Inc. trades at an EV/EBITDA multiple of 13.67 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.68 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 43.70M versus a market cap of 31.09M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Rubicon Organics, Inc. maintains a current ratio of 2.21, meaning it holds 2.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 36.78, indicating elevated leverage, while an interest coverage ratio of 3.85 demonstrates adequate ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Rubicon Organics, Inc. posted a negative return on equity (ROE) of -4.09, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -2.63, reflecting losses generated across the asset base. The company generates approximately 254,883.44 in revenue per employee across its workforce of 252.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.10 indicates how many times Rubicon Organics, Inc. sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 22, 2026, Rubicon Organics, Inc.'s stock has declined approximately 20.91% over the past 52 weeks. The 50-day moving average sits at 0.49, while the 200-day moving average is 0.49.

Over the twelve months ended June 30, 2026, Rubicon Organics, Inc. generated 64.23M in revenue and converted that into -1.74M in net income, yielding earnings per share of -0.02. EBITDA reached 3.20M, while operating income came in at -894,324.00.

As of June 30, 2026, Rubicon Organics, Inc. holds 2.96M in cash and equivalents against 15.58M in total debt, resulting in a net debt position of 11.13M. Total book value stands at 42.35M, with working capital of 20.89M providing operational flexibility.

Rubicon Organics, Inc. produced -2.49M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -5.20M in capital expenditures, free cash flow totaled -7.69M - equivalent to -0.11 per share.

Over the twelve months ended June 30, 2026, Rubicon Organics, Inc. posted a gross margin of 35.99, reflecting its pricing power and cost economics. The operating margin of -1.39 and net profit margin of -2.71 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Rubicon Organics, Inc. paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield is negative at -23.49: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -11.16, meaning Rubicon Organics, Inc. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, Rubicon Organics, Inc. has an Altman Z-Score of -0.03, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.